3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Neoplasms
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Neoplasm Metastasis
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Head and Neck Neoplasms
1
GastroEsophageal Cancer
1
Gallbladder Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
CLDN18.2 Positive
1
Anal Cancer Metastatic
1
Interventions
pembrolizumab
6
Nivolumab
6
enfortumab vedotin
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
4
sacituzumab govitecan
3
Docetaxel
3
CTLA-4 Antigen
3
cabozantinib
2
Taxes
2
Paclitaxel
2
Gemcitabine
2
relatlimab
1
eribulin
1
avelumab
1
atezolizumab
1
Single Person
1
Radiosurgery
1
Platinum
1
Cisplatin
1
Carboplatin
1
Axitinib
1
Antineoplastic Protocols
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Albumin-Bound Paclitaxel
×
30 days
×
Clear all
No trials found.